152 related articles for article (PubMed ID: 8145727)
1. Pituitary cell line GH3 expresses two somatostatin receptor subtypes that inhibit adenylyl cyclase: functional expression of rat somatostatin receptor subtypes 1 and 2 in human embryonic kidney 293 cells.
Garcia PD; Myers RM
Mol Pharmacol; 1994 Mar; 45(3):402-9. PubMed ID: 8145727
[TBL] [Abstract][Full Text] [Related]
2. Human somatostatin receptor, SSTR2, is coupled to adenylyl cyclase in the presence of Gi alpha 1 protein.
Kagimoto S; Yamada Y; Kubota A; Someya Y; Ihara Y; Yasuda K; Kozasa T; Imura H; Seino S; Seino Y
Biochem Biophys Res Commun; 1994 Jul; 202(2):1188-95. PubMed ID: 7914078
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of two cloned somatostatin receptors.
Rens-Domiano S; Law SF; Yamada Y; Seino S; Bell GI; Reisine T
Mol Pharmacol; 1992 Jul; 42(1):28-34. PubMed ID: 1353250
[TBL] [Abstract][Full Text] [Related]
4. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase.
Patel YC; Greenwood MT; Warszynska A; Panetta R; Srikant CB
Biochem Biophys Res Commun; 1994 Jan; 198(2):605-12. PubMed ID: 7905265
[TBL] [Abstract][Full Text] [Related]
5. The somatostatin receptors SSTR1 and SSTR2 are coupled to inhibition of adenylyl cyclase in Chinese hamster ovary cells via pertussis toxin-sensitive pathways.
Hershberger RE; Newman BL; Florio T; Bunzow J; Civelli O; Li XJ; Forte M; Stork PJ
Endocrinology; 1994 Mar; 134(3):1277-85. PubMed ID: 7907016
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
Panetta R; Greenwood MT; Warszynska A; Demchyshyn LL; Day R; Niznik HB; Srikant CB; Patel YC
Mol Pharmacol; 1994 Mar; 45(3):417-27. PubMed ID: 7908405
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin and its receptor family.
Patel YC
Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
[TBL] [Abstract][Full Text] [Related]
8. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
Hadcock JR; Strnad J; Eppler CM
Mol Pharmacol; 1994 Mar; 45(3):410-6. PubMed ID: 8145728
[TBL] [Abstract][Full Text] [Related]
9. Both overlapping and distinct signaling pathways for somatostatin receptor subtypes SSTR1 and SSTR2 in pituitary cells.
Chen L; Fitzpatrick VD; Vandlen RL; Tashjian AH
J Biol Chem; 1997 Jul; 272(30):18666-72. PubMed ID: 9228036
[TBL] [Abstract][Full Text] [Related]
10. Gi alpha 1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: identification of the functional domains of this alpha subunit necessary for mediating the inhibition by somatostatin of cAMP formation.
Law SF; Zaina S; Sweet R; Yasuda K; Bell GI; Stadel J; Reisine T
Mol Pharmacol; 1994 Apr; 45(4):587-90. PubMed ID: 8183236
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin inhibits interleukin 6 release from rat cortical type I astrocytes via the inhibition of adenylyl cyclase.
Grimaldi M; Florio T; Schettini G
Biochem Biophys Res Commun; 1997 Jun; 235(1):242-8. PubMed ID: 9196070
[TBL] [Abstract][Full Text] [Related]
12. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
13. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase.
Reisine T; Kong H; Raynor K; Yano H; Takeda J; Yasuda K; Bell GI
Mol Pharmacol; 1993 Nov; 44(5):1016-20. PubMed ID: 7902529
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
[TBL] [Abstract][Full Text] [Related]
15. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
[TBL] [Abstract][Full Text] [Related]
16. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
[TBL] [Abstract][Full Text] [Related]
17. Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association.
Kong H; Raynor K; Yasuda K; Bell GI; Reisine T
Mol Pharmacol; 1993 Aug; 44(2):380-4. PubMed ID: 8102784
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase.
Yamada Y; Reisine T; Law SF; Ihara Y; Kubota A; Kagimoto S; Seino M; Seino Y; Bell GI; Seino S
Mol Endocrinol; 1992 Dec; 6(12):2136-42. PubMed ID: 1337145
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells.
Bruno JF; Xu Y; Berelowitz M
Biochem Biophys Res Commun; 1994 Aug; 202(3):1738-43. PubMed ID: 7914724
[TBL] [Abstract][Full Text] [Related]
20. Multiple effector coupling of somatostatin receptor subtype SSTR1.
Kubota A; Yamada Y; Kagimoto S; Yasuda K; Someya Y; Ihara Y; Okamoto Y; Kozasa T; Seino S; Seino Y
Biochem Biophys Res Commun; 1994 Oct; 204(1):176-86. PubMed ID: 7524497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
